STTR Phase I: Engineering a recombinant methane monooxygenase to convert methane to methanol for the production of fuels and chemicals
Award amount
$225,000Program and phase
STTR · Phase IAward year
2014Award details
- Awarding agency
- National Science Foundation
- Branch
- Not reported
- Recipient company
- PROTABIT, LLC
- Proposal award date
- 2014-01-01
- Contract end date
- 2014-12-31
- UEI
- ZMG1FJD9SQ64
- Solicitation number
- Not reported
- Topic code
- BC
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- High-Throughput Engineering of Bispecific Antibodies
- STTR Phase II:Artificial Intelligence (AI)-based Development of Neutralizing Antibodies for SARS-CoV-2
- STTR Phase I: COVID-19: AI-based Development of Neutralizing Antibodies for SARS-CoV-2
- Advancing Protein Engineering Using Artificial Intelligence and the ProtaBank Mutation Database
- PEBank: A database for protein engineering data
Research funding history
13 SBIR/STTR records share this UEI (2012–2025). Reported award amounts total $8,668,038. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation, Department of Energy